What are peptides? A guide for researchers

Peptides are at once very simple and extremely diverse. Simple because they are basically a chain of amino acids. Diverse because just a few amino acids can change how a molecule binds to a receptor, how long it stays in the body and what response it triggers.

This guide is a starting point for understanding peptides in a research context. It does not address dosing or treatment, but structure, mechanism, types and the limits of evidence.

What is a peptide?

A peptide is a molecule composed of amino acids linked by peptide bonds. A peptide bond forms between the carboxyl group of one amino acid and the amino group of another, releasing a molecule of water.

Chain length is measured by the number of amino acids:

• oligopeptides have a few amino acids (often up to 10–20);
• polypeptides are longer chains;
• proteins are usually longer and more complex structures.

The boundary between peptide and protein is not the same everywhere. A common convention is that peptides are chains of up to about 50 amino acids, but this is not a strict biological rule. Structure and function matter more than the number.

How do peptides work?

Peptides are often signalling molecules. They bind to receptors on the surface of cells or inside them and trigger a cascade of events. A few examples:

Peptides can also act as:

• antimicrobial substances that damage bacterial membranes (e.g. LL-37);
• building blocks or fragments of larger proteins;
• enzyme inhibitors;
• immunomodulators that influence immune cell signalling.

The key point is that no peptide is universally “good” or “bad”. The effect always depends on context: which receptors the tissue has, how much peptide is present and for how long.

Natural and synthetic peptides

Natural peptides are produced in organisms by the breakdown of larger proteins or through specific enzymatic pathways. Synthetic peptides are made in the laboratory, often by chemical synthesis or recombinant technology.

A synthetic peptide can be:

• identical to a natural sequence;
• an analogue with small changes that improve stability;
• a fragment of a larger protein;
• modified with additional groups (acetylation, lipidation, cyclisation).

These modifications are often precisely why a peptide is useful as a research tool or a medicine. At the same time, they mean that two peptides with similar names can behave quite differently.

Why are peptides interesting for research?

Peptides offer high specificity. Unlike small molecules, they can closely mimic natural signalling sequences and thus target particular receptors. Modern medicine already uses this: insulin, glucagon, some GLP-1 agonists and many vaccines are based on peptides or their derivatives.

They are also attractive for research because they can be synthesised and modified relatively quickly. This makes it possible to study which part of the molecule is responsible for binding and which for stability.

What does “research peptide” mean?

The label RUO (Research Use Only) means that the product is intended for laboratory research and not for clinical use. It is not a marketing phrase but a legal and safety category.

Several consequences follow:

• the product has not been approved as a medicine;
• it is not intended to diagnose, treat or prevent disease;
• it is not intended for ingestion or injection in humans;
• quality is assessed by analytical parameters, not clinical outcomes.

For the researcher this means taking responsibility for an appropriate protocol, safety and compliance with local legislation.

How to read studies about peptides?

In research it helps to keep the hierarchy of evidence in mind:

1. cell cultures — show a mechanism, not a clinical effect;
2. animal models — show effects in a complex organism, but with different biology;
3. small human studies — can indicate a direction, but are often underpowered;
4. randomised controlled trials — the strongest evidence for clinical efficacy;
5. systematic reviews and meta-analyses — summarise multiple studies and show consistency.

If a claim rests on a single mouse study, it must not be presented as a proven benefit for humans. It is also necessary to check whether the study was peer-reviewed, who funded it and whether the results have been independently replicated.

Why is purity so important?

Peptides are sensitive to degradation, oxidation and aggregation. Impurities can:

• reduce the actual amount of active compound;
• trigger an immune response;
• distort experimental results;
• make comparisons between studies difficult.

That is why HPLC (purity assessment) and mass spectrometry (identity confirmation) are the basic analytical steps. The certificate of analysis must be tied to a specific batch, not to a generic product name. Read more in the article How to read a certificate of analysis.

Common misconceptions

• “A peptide is natural, so it is safe.” Natural substances can be highly biologically active and dangerous.
• “If it works in mice, it works in humans.” Biological differences can be large.
• “Higher purity means a stronger effect.” Purity ensures fewer impurities, not greater biological activity.
• “All peptides are steroids.” They are entirely different chemical groups.

Conclusion

Peptides are one of the most productive research groups in modern biomedicine, and at the same time a field where scientific hypotheses quickly turn into marketing promises. Distinguishing between mechanism, preclinical result and clinical evidence is the basic hygiene of thinking.

To continue, browse the catalogue of research peptides or read the guide to the legal framework in Croatia.